Craig is the Professor of Psychiatry of Ageing at the University of Edinburgh, Director of Edinburgh Centre for Dementia Prevention and Director of Brain Health Scotland.  He was elected Chair of SDRC in 2018 and has driven forward on his commitment to promote and grow that consortium to assist Scotland and Scottish Based Researchers from all over the world to achieve its objectives and theirs.

His primary research interest is the maintenance of brain health in mid-life to mitigate the risks of initiation and progression of degenerative brain disease that may lead to dementia. He is Chief Investigator on the PREVENT Dementia and European Prevention of Alzheimer’s Dementia Research Programmes.

Louise is a Reader in Dementia Research in the Alzheimer Scotland Centre for Policy and Practice at the University of the West of Scotland.

She is a psychologist with a focus on applied psychosocial research that aims to improve the lives of people living with dementia, their families and people who care for them.

In 2013 Debbie was appointed as the Alzheimer Scotland Professor of Dementia and inaugural Director of the Alzheimer Scotland for Policy and Practice at the University of the West of Scotland. 

She has been research active since completing her doctorate in 1995 at Glasgow Caledonian University. As a founding member of SDRC she has championed a focus on early career researchers, and is particularly proud to have supervised, led or been involved in practice based research studies that are developing caring interventions and challenging approaches to advanced dementia care in Scotland, Europe and beyond.

Edo Richard is Professor of neurology at Radboud University in Nijmegen and has a part-time position at the department of Public Health at Amsterdam UMC, both in The Netherlands. He combines hic clinical work as a neurologist with research into dementia, in particular prevention. He was one of the main investigators of the preDIVA trial, the only trial to date using all-cause dementia as primary outcome. He is the PI of the EU-funded HATICE and PRODEMOS projects, investigating an eHealth and mHealth approach to reduce dementia risk. He also has an interest in ethical aspects of early diagnosis and risk disclosure, particularly in relation to prevention.

Terry holds the post of Senior Clinical Lecturer and Honorary Consultant Stroke Physician in the Institute of Cardiovascular and Medical Sciences, University of Glasgow.

Terry combines his broad research portfolio with active teaching and clinical commitments.

His primary research interest is the maintenance of brain health in mid-life to mitigate the risks of initiation and progression of degenerative brain disease that may lead to dementia. He is Chief Investigator on the PREVENT Dementia and European Prevention of Alzheimer’s Dementia Research Programmes.

Kieren joined the University of Strathclyde Computer Information Sciences department in 2018. His particular research interest is in non-communicable disease including dementia, ageing populations, mental health alongside the potential role of digital health in future healthcare. His PhD work involved a systematic review of candidate dementia interventions with the CAMARADES group at the University of Edinburgh (http://www.dcn.ed.ac.uk/camarades/default.htm) and derived a number of evidence based reasons as to why candidate interventions do not always succeed in clinical trials. 

Sarah is a PhD researcher and study coordinator in the Edinburgh Dementia Prevention group at the University of Edinburgh. Her PhD research looks at the HPA axis (our stress system) and its impact on risk for Alzheimer’s disease. She has over 10 years of experience working in the field of dementia research, with specialisms in clinical trials and cohort studies for people living with dementia, mild cognitive impairment, mental health conditions and healthy volunteers. 

Rose is a second year PhD student at ECRED (Edinburgh Centre for Research on the Experience of Dementia) and Alzheimer Scotland Dementia Research Centre. She is interested in developing ways to work in partnership with people living with young onset dementia to address needs in research, support, and services

Miriam Scarpa is a final year PhD researcher at the University of Glasgow Centre for Translational Pharmacology, funded by an MRC-iCASE studentship in collaboration with Eli Lilly and company. Her research investigates G protein-coupled receptors (GPCRs) as drug targets for the symptomatic and disease-modifying treatment of neurodegenerative conditions, with particular focus on the M1 muscarinic acetylcholine receptor

Samantha Wilson is a second-year PhD student at the University of Liverpool. Her PhD explores how people living with dementia use their everyday smartphone and tablet devices to support their memory and cognition.